{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:39:25Z","timestamp":1784651965317,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.eimc.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:19:56Z","timestamp":1540945196000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain"],"prefix":"10.1016","volume":"37","author":[{"given":"Hernando","family":"Knobel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Suarez-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Antela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Ram\u00f3n","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fulladosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Refollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2018.09.015_bib0155","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.eimc.2018.09.015_bib0160","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015","volume":"3","author":"Wang","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eimc.2018.09.015_bib0165","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/cid\/cir628","article-title":"Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses","volume":"53","author":"Capeau","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2018.09.015_bib0170","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw097","article-title":"HIV as a chronic disease: evaluation and management of non-AIDS-defining conditions","author":"Serrano-Villar","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.eimc.2018.09.015_bib0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","article-title":"Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study","volume":"71","author":"Legarth","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2018.09.015_bib0180","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2018.09.015_bib0185","first-page":"75","article-title":"Morbidity in older HIV-infected patients: impact of long-term antiretroviral use","volume":"16","author":"Guaraldi","year":"2014","journal-title":"AIDS Rev"},{"key":"10.1016\/j.eimc.2018.09.015_bib0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2018.09.015_bib0195","doi-asserted-by":"crossref","first-page":"e59551","DOI":"10.1371\/journal.pone.0059551","article-title":"Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review","volume":"8","author":"Bavinger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.eimc.2018.09.015_bib0200","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit043","article-title":"Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study","volume":"207","author":"Ryom","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2018.09.015_bib0205","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2352-3018(15)00211-8","volume":"3","author":"Mocroft","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eimc.2018.09.015_bib0210","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":"Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2018.09.015_bib0215","unstructured":"Ryom L, Lundgren J, El-Sadr W, et al. D:A:D study group. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. Lancet HIV.(in press)."},{"key":"10.1016\/j.eimc.2018.09.015_bib0220","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/cid\/civ014","article-title":"Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care","volume":"60","author":"Klein","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2018.09.015_bib0225","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/ndt\/gfr657","article-title":"Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients","volume":"27","author":"Ibrahim","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.eimc.2018.09.015_bib0230","unstructured":"National Kidney Foundation. K\/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (suppl): 1-266."},{"key":"10.1016\/j.eimc.2018.09.015_bib0235","first-page":"2560","article-title":"National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection","volume":"289","author":"Chobanian","year":"2003","journal-title":"Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA."},{"key":"10.1016\/j.eimc.2018.09.015_bib0240","unstructured":"Anonymous. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2006; 26 (suppl 1): 43-48."},{"key":"10.1016\/j.eimc.2018.09.015_bib0245","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program. Third Report of the National Cholesterol Education Program on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1016\/j.eimc.2018.09.015_bib0250","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","article-title":"International Society for Clinical Densitometry: 2007 Adult and Pediatric Official Positions","volume":"43","author":"Lewiecki","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.eimc.2018.09.015_bib0255","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.eimc.2018.09.015_bib0260","doi-asserted-by":"crossref","first-page":"e1001809","DOI":"10.1371\/journal.pmed.1001809","article-title":"Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study","volume":"12","author":"Mocroft","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.eimc.2018.09.015_bib0265","unstructured":"DHHS. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. https:\/\/aidsinfo.nih.gov\/guidelines.(accessed June 2018)."},{"key":"10.1016\/j.eimc.2018.09.015_bib0270","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0000000000001547","article-title":"Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation","volume":"31","author":"Alvarez","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2018.09.015_bib0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis","volume":"13","author":"Islam","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.eimc.2018.09.015_bib0280","first-page":"184","article-title":"Is tenofovir alafenamide safer than tenofovir disoproxil fumarate for the kidneys?","volume":"18","author":"Aloy","year":"2016","journal-title":"AIDS Rev"},{"key":"10.1016\/j.eimc.2018.09.015_bib0285","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/QAD.0b013e32833202e2","article-title":"Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations","volume":"24","author":"Rodr\u00edguez-N\u00f3voa","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2018.09.015_bib0290","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/cid\/cix1083","article-title":"ACTG A5353: a pilot study of dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500,000 copies\/mL","volume":"66","author":"Taiwo","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2018.09.015_bib0295","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(17)31917-7","article-title":"Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial","volume":"390","author":"Margolis","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2018.09.015_bib0300","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jamainternmed.2017.4349","article-title":"Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States","volume":"177","author":"Reddy","year":"2017","journal-title":"JAMA Intern Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X18302799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X18302799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T22:27:45Z","timestamp":1720736865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X18302799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0213005X18302799"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2018.09.015","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}